CSS »

Integra Lifesciences Hldgs C shares owned by CSS

Quarter-by-quarter ownership of Integra Lifesciences Hldgs C shares owned by CSS from 13F filings

Historical chart of CSS investment in Integra Lifesciences Hldgs C

Tip: Access up to 7 years of quarterly data

All positions including Integra Lifesciences Hldgs C held by CSS consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Integra Lifesciences Hldgs C by CSS

Quarter filed Position value Share count Share price at filing
2023-03-31 $18M 18M 0.98
2022-12-31 $5.8M 5.9M 0.97
2022-09-30 $2.6M 2.9M 0.88
2021-06-30 $9.9M 9.0M 1.10
2021-03-31 $5.6M 5.0M 1.12

More positions owned by CSS

Royal Caribbean Group Note 6.000% 8/1 (Principal)
Noble Corp Ord Shs A (NE)
Ark Etf Tr Innovation Etf Call Option (ARKK)
American Airlines Group Note 6.500% 7/0 (Principal)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Mirati Therapeutics
Macom Tech Solutions Hldgs I Note 0.250% 3/1 (Principal)
Peabody Engr Corp Note 3.250% 3/0 (Principal)
Ionis Pharmaceuticals Note 4/0 (Principal)
Royal Caribbean Cruises Put Option (RCL)
Splunk Note 1.125% 9/1 (Principal)
American Airls Put Option (AAL)
Ncl Corp Note 5.375% 8/0 (Principal)
Marriott Vacations Worldwide Note 1/1 (Principal)
Brookdale Sr Living Unit 11/15/2025 (BKDT)

View all positions for CSS

Top funds holding Integra Lifesciences Hldgs C

Highbridge Capital Management
III Capital Management
Citigroup
MacKay Shields
Balyasny Asset Management
Aviva
Tenor Capital Management
Capstone Investment Advisors
Aequim Alternative Investments
Wells Fargo & Company
Osterweis Capital Management
Wellington Management Company
Shenkman Capital Management
Bank Of Montreal
DLD Asset Management

View all funds holding Integra Lifesciences Hldgs C